issue
supplied
taken
london
potentially
omitted
1250
gray
conclusions
felicity
declared
luppi
728
mi
metastasis
perioperative
rarely
cpg2_10u
address
diaz
om
mild
wehler
substituting
project
advise
phosphatase
estimate
share
adj5
option
death
graphs
appropriate
rate
dramatically
ran
protection
1266
outcome
comprises
peter
schilsky
gabbay
biotech
palmer
reducing
show
chicago
casts
lack
tennvall
lancs
even
adenis
retro
qlq
involve
mason
leonard
jl
charnley
1980s
haemorrhage
em
final
klapdor
panel
excess
413
la
already
neuq
mozzicafreddo
1981
howe
knowledge
exchange
incurred
heavily
arms
vaitkevicius
discontinuation
comparator
registry
fitzsimmons
summaries
cullum
varies
personal
repositioned
commendable
farmacia
lipiodol
aetiology
somnolence
2250
suspension
mortimore
radical
keyword
dorset
physicians
mation
web
dimopoulous
neoplasm
partly
references
andren
set
1988
contd
capture
salford
surg
referred
panucci
loco
sion
freeman
crib
perfect
spentzouris
birth
provider
both
metalloproteinase
karnofsky
rev
inequality
jw
no
ecco
ratios
ospedaliera
dissemination
eventual
russell
12821
denoted
colleagues18
register
burris
recommendation
gemzar
haperen
profound
mortality
2505
route
disease
fabbrocini
behind
ashtead
compromised
societa
inconsistently
overexpression
dr
icrf
genetics
jones
leuco
character
glasgow
closely
dsri
age
intercollegiate
plain
expanded
higher
l25
tests
results
birmingham
004
late
htacd
minimise
simpli
hci
catheters
wilkin
costings
validate
establishment
devastating
necessary
extent
moss
four
mesenteric
exeter
kurtz
hypothetical
drawback
recommendations
experience
600
tract
individual
topic
qualitative
purchased
coates
2015
vol
laboratories
prolongs
database
calandri
calculate
leading
indication
pathological
neal
anticancer
studies
105
flushings
4500
2380
expenses
ireland
intensive
elderly
considerably
widespread
advocate
utility
l4720
database7
college
hohenberger
provide
168
bacup
wieand
gemcytabine
fol
universities
implications
300a
roznowski
ssci
identified
shows
julietta
dare
recombinant
timespan
351
concerning
adequately
description
agence
southern
series
conservative
purchase
resource
combination
bay12
extrapolate
pvi
refused
dismal
hidalgo
regimen
investigate
original
increase
maroun
pharmacy
popay
absolute
dosage
pozzo
2001
published
aetmis
0025
months
widely
feedback
02392
1400
past
lamping
discount
mtrac
gave
mcmaster
under
sequence
silva
endoscopic
preceded
distinct
earlier
determined
bartholomew
riedel
strangeways
sch
toxicity
superior
accepted
ast
operable
medical
979
hierarchy
surrey
records
vomiting
end
theory
sending
resectable
4320
purely
reliable
hochmuth
genase
christine
diagnoses
placebo
without
fever
earliest
department
565
reviews
reduction
samantas
identified80
appointment
follow
continued
062
rapid
brian
methodology
chair
fractions
italiana
practice
order
bruce
rater
opposed
cochrane
registrations
as
316a
ae
savings
acknowledgement
l30
1997
integration
collation
variables
agency
andersen
assessment
relapsed
child
calibrate
brocic
document
shortened
centre
intelligence
org
default
progres
send
limitations
cautiously
herg
nosov
experienced
capsules
4839
wide
deemed
your
148
scoring
bone
157
actual
rc
cortes
fields
differ
resulted
morabito
providers
szczepura
criteria
345
histologic
952
gen
exocrine
consistent
nitrogen
antenatal
murad
eight
forward
compared
faraggi
glimelius
combinations
did
garcia
cull
method
jonothan
any
define
marsico
more
cross
heed
patterns
carboplatin
report
class
september
pharmacists
demonstrate
usage
l15
validity
seri
relevant
gressed
phase
procedure
neither
part
fa
eortc
iii
982
fact
seen
inconclusive
drug
subscription
leeds
only
riemann
rosemurgy
234
pharmaco
proceedings
recorded
1000
sometimes
knowles
193
park
james
119
cancerguide
fufa
annum
levin
seven
good
dependent
kayitalire
suppress
provision
kresek
concern
farmer
systematic
stays
state
cgy
cf
delayed
associated
ihe
5730
osoba
george
least
insertion
less
overestimation
buchler
unfortunately
scottish
cytoimplant
midland
forman2
virgo
almost
gompertz
instruments
110
value
finding
died
berlin
studies76
cast
pancreas
science
descriptions
mr
herrero
relied
robust
august
input
empirically
crd
investi
nowotwory
termed
individuals
556
secondary
some
soton
schroeder
committee
wade
cheque
cairns
improvement
respect
fails
549
certainly
fey
woods
bury
multicentric
lists
benefits
feasibility
tolerability
basis
583
wilkowski
ohe
improve
resources
cunningham
cbr
abrams
employed
espac
detected
dennett
adjustment
levels
aravandinos
rapidly
resection
accurate
chris
multicentre
320
jovtis
familial
unsatisfactory
one77
intense
mind
des
older
criticises
vative
manual
oxon
berberabe
break
pecelj
l100
flutamide
lower
comprising
diarrhoea
specific
pc
castro
design
underestimate
agencies
ideally
interests
l8527
becomes
signorelli
males
components
deputy
reiterated
occurred
harris
rowinsky
northern
oxford
ferreri
except
abstracts
initiative
aggressive
cbra
uft
ranging
entered
l3
sms
policies
manner
kroner
advertising
anaesthetist
exclusively
opinion
consultant
curve
commercial
3000
279a
alkaline
worse
dean
sufferers
austria
progressed
adrian
recent
institutes
heinemann
clements
wyatt
sources
injections
followed
nutrition
medians
chartered
directed
suitable
meant
pancera
mitoxantrone
l10
cohort
hospital
neto
marker
form
1065
give
unique
confirmation
ferguson
morris
figure
annual
node
being
executive
cookridge
3537
ongoing
costs
chief
cardiac
pef
http
eva
1999
twist
may
medicinal
operations
neoplas
different
infobase
depression
arlauscas
mid
heron
netten
novel
consensus
eed
sept
mishaeli
hamm
earle
mayo
illustration
int
number
shields
fahey
relevance
universal
population
fu
produce
standardised
300
illustrative
how
identical
ares
milford
therefore
having
writer
king
question
ness
subtotal
carried
tablet
also
related
heritage
mt
gramont
improving
freelance
epidemiological
pay
correspond
like
ranged
harvard
5639
2264
tony
managing
acknowledged
undertaken
ha
include
suppression
stoke
cut
his
126
limiting
651
arif
reliability
worldwide
shpic
1200
ml
mf
adobe
asco
meaning
french
cu
depend
complications
extracted
unit
gravalos
pain
piazza
page
angelelli
chemo
215
tegafur
shape
drsi
assigning
equivalent
morris2
example
discussed
june
exception
falling
mrs
north
ducts
assessed
combining
programme
994
l7500
kenzi
economic
time
ward
2140
unvalidated
adjuvant
19317
disagreements
yeo
429
human
comparatively
evaluating
neville
barry
vicario
complex
pa
indexed
neonatal
bibliographic
phone
apparent
has
lencioni
ken
crino
unpublished
fitting
103
ccohta
anchisi
medica
s0
1219
chemoradiotherapy
proteolytic
useful
declining
804
hypersensitivity
medication
continue
grant
sufficiently
library
utilities
consortium
leucocyte
markedly
pounsford
l330
week
until
478
retrospective
appro
basingstoke
rodriguez
lygidakis
ageing
derbyshire
lukacevic
randomisation
35th
confidence
therapy
rct13
colegate
pan
haematuria
l3568
con
poorer
distant
charge
suspended
rep
ks
rare
facility
inferior
arnaoutis
fellow
randomized
johns
observed
via
matano
suggestion
regulatory
biotechnology
perform
spagnuolo
involves
range
fd
contentious
particularly
effect
stay
localised
formulations
rightly
studies80
l109
r115777
place
primary
firstline
gelber88
1100
yorkshire
study20
email
million
66336
nicky
withdrawal
512
targeting
psychiatry
burnside
recurrent
bulat
consistently
verified
bazin
vessels
access
board
l20
figures
l12
tutor
breast
ionta
knight
setting
authority
kelson
context
definite
supported
nature
there
uncertainties
mended
market
180
hopkins
implicit
provides
top
l3234
certain
hobbs
professional
oakwood
varying
directly
arising
es
875
occurs
heru
manifested
inter
government
smetzer
authors
york
contact
kornek
should
surmised
operative
plateaued
compounds
deduct
baughman
mention
alici
frequently
thrombocytopenia
aykan
men
newcastle
clinical
cornwall
properly
0008
subtracting
index
8059
encompass
off
subscriptions
treating
unclear
additional
visits
5fu
ancreatic
assumption
director
city
underestimation
radiotherapy
dfdc
961
improves
objectives
clancy
infrastructure
propor
londonderry
result
paclitaxel
dec
microangiopathic
text
liaison
findings
grace
proleukin
perisic
vhn
dc
per
performed
interval
fewer
computed
proteinase
shulman
infor
postoperative
cpg
fein
referees
2200
veit
sensitive
consulted
indicated
mm
business
casper
watt
loukas
important
owing
comparison
all
periods
british
930
attain
undergoing
648
units
nh
kelsen
midwifery
admission
apc
labianca
202
361
total
ineffectual
development
infused
add
gv
addenbrooke
surgery
factor
ryan
gem
including
control
sciences
dorta
surgical
itself
complete
villa
supportive
tyne
gallego
uation
applications
konig
1240
mw
html
germond
below
lorenzo
hta
cases
grade
billingham
methods
2366
duration
ramalu
infusion
prog
rcts12
decreasing
rigatos
polyzos
papakostas
comment
voi
fe
warnings
details
toxicities
significant
raltitrexed
becagli
tioned
contained
krook
attributed
hammond
manchester
post
intravenous
simultaneous
comes
ears
311a
so16
opposite
hl
enas
journals
inhibitor
adverse
handsearched
removal
sbu
085
showing
language
suggest
release
marimistat
upward
classification
coordinating
alternative
broadly
libroia
distinguish
substantially
effects
protein
cards
joan
rotblat
multi
implica
bolus
concerned
simon
martin
reasonably
herc
life
herceptin
stat
symptoms
brings
adriamycin
chemoimmunotherapy
every
national
policy
135
petrovic
scalabrini
care
addressed
s2
webster
cytidine
e3296
modiano
cr
measured
study
arm
langrehr
affect
survive
errors
1419
surgeons
transsplenic
slight
camden
scharr
method94
about
articles
defined
somatostatin
hormonal
gastrointestinal
exceeds
workers90
together
forman
lar
format
histologically
vincent
changing
normal
200
assumes
own
hs
larvin
monitoring
curative
cancer_dept
investigators
ridgeway
allen
rel
cantore
lad
lived
d15
competing
resolved
1157
hinrichs
blinding
examine
severity
bypasses
contents
retrograde
moore
independently
neo
successive
depisch
large
variations
cecchi
platinum
273a
annually
attempt
cc
methodological
fischer
treatment
gathered
wilson
commissioned
long
credit
specialists
ates
reductions
measure
clinicaltrials
initial
acrobat
expect
central
seems
316
synthesising
tion
releases
retrospectively
fax
southmead
aware
lead
lv
chemoradiation
campbell
scenario
council
bulletins
castellano
cd
fink
estim
authoritative
cancers9
versus
childbirth
rcts19
examining
nottingham
recruiting
granulocyte
vk
furthermore
reported
fall
lyg
randomised
recruited
mined
indicator
technologies
observational
professor
scheithauer
whether
guidance
venous
hearing
was
frenchay
diet6
l7209
thanks
paz
carrato
role
assess
ragnarson
experi
minor
tropical
priate
countries
howard
103882
qalys
identification
definitively
half
l33
progression
issn
efficient
close
available
laurencet
drawn
however
double
unusually
patients
flebiger
confidential
colon
hammel
minimum
nausea
wein
decision
caveats
396
site
year
net
laboratory
picozzi
considered
accrual
gastric
approval
te
alternately
tel
frontini
private
eighth
listed
title
palliative
plunkett
objective
still
lilly
direction
lj
will
325
cohorts
nick
future
teacher
cause
emphasis
marsden
usually
pathologically
nice
colorectal
thame
produced
160
component
274a
uncontrolled
macroscopic
histo
barni
numbers
410
hj
tomudex
kitson
indeed
rash
417
stopped
then
markers
difluorodeoxycytidine
comput
teaching
direct
mucositis
oedema
nigel
sideration
blood
involving
weeks
feasible
744
increased
frequent
six
quality
zickero
food
intensity
raw
conform
daily
conclusive
similar
consecutive
1995
combine
liverpool
radstone5
falcone
same
indicate
modality
hmso
criticism
tracy
pathologist
oncologic
campaign
attributable
tool
monograph
rcts
enander
age9
colleagues13
167
aspects
insen
given
ensure
250
middlesex
fletcher
darwish
deterioration
separate
130
principal
article
2392
l14
symptom
serum
book
peer
kokoska
clin
acceptable
delta
expert
carter
cavazini
acute
branch
sensitivities
anaemia
contexts
offer
939
haggard
morphine
formulary
publication
langendijk
www
adequate
looked
blaszowsky
diseases
eastern
programmes
antonisse
southampton
problems
determination
cooperative
william
115
must
body
characteristics
aboulafia
morgan
single
concurrent
oxaliplatin
ricci
simes
239
haider
clinicians
087
arbitrarily
cavallo
clearly
patnick
nos
lost
derivation
trippoli
written
limited
dentistry
alive
completed
within
obtained
theodoracopoulos
led
points
pancreatectomy
abdominal
nicholl
generate
priced
trip
response
ward1
because
condition
l9468
douglas
classed
prefer
palliation
bank
marzec
ncdb
consumables
unproven
msac
smaller
arning
occurring
dissertation
parisons
frequency
tnm
historically
milne
centerwatch
269a
espac3
management
unreasonable
jacobsson
razvillas
experimental
equal
jf
sandberg
ahfmr
constipation
206
delivery
vary
relapse
survival
castilla
used
johanson
papworth
steps
pssru
true
l31
press
when
background
reached
alvarez
pharmacoeconomic
argue
incidence
broader
ii
keeley
mcguire
conduct
pedicini
accept
polckow
yes
larvin4
solid
7px
mode
l36
continually
sign
base
colony
lang
smc
379
randomly
influence
institute
ca
causes
bansback
associate
consisted
questionable
370
adjacent
beneficial
mani
800
revision
comprehensive
forthcoming
darton
administration
nhmrc
names
adjusted
point
sdu
assumed
performance
liver
pur
ilv
kyriakou
markham
specified
expectation
small
orlandi
eurocard
limits
exercised
kerr
transaminases
goldhirsch
tionately
comella
repeated
achieving
pancrea
sante
cj
marrow
low
ly188011
fifty
jennie
through
searchable
while
sixth
modification
sitive
hewison
developed
minute
purposes
claimed
colucci
proffered
hospitalisations
ncchta
formal
caillouette
finally
suffer
overstated
circumstances
tions
immunotherapeutic
gators
150
7000
gastroenterology
neoplasms
instances
decreased
mant
immuno
pharmacist
see
statement
marantz
492
cameron
buckels
intra
either
designated
simplicity
review
clemens
heelan
values
rehabilitation
clifford
interpreted
artery
informative
damiano
stathopoulos
trillet
concerns
quoted
bun
hatty
adult
multiplying
al
314a
criticisms
290a
section
consist
specialist
size
estimates
invest
cinoma
publish
side
conser
escalated
fluorouracil
membership
alopecia
trent
organisation
enough
crellin3
designs
modern
paraesthesias
doses
safety
poster
commencing
hiru
ledgement
jadad
jenifer
majority
fda
instance
simply
contraindications
weston
1966
certainty
conjunction
existing
schedules
protocol
giscad
manitoba
metallomatrix
172
consists
works
stomach
us
highest
sheffield
tomao
apostolopoulos
reproduction
avoided
cannot
meta
practitioner
spectrum
proportionally
creatic
frances
mp
123
severe
reduced
times
jd
cardiothoracic
hagan
replication
garin
5278
checked
team
thrombo
326a
masi
265a
overall
modulated
240a
registers
urea
458
corfe
accurately
medicine
kathlyn
tagliaferri
shown
printer
excluded
trust
vancouver
infusional
electronic
350
bay
greul
curves
slotman
escalating
reni
lampert
macmillan
parker
throughput
ron
biochemistry
2002
valuation
regi
conducting
giving
eur
meier
nutritional
301a
tables
importance
prolongation
people
sensitivity
identify
treated
inaugural
source
processes
local
klein
0001
reader
item
whom
rk
finish
ltd
characterised
eligible
uracil
1991
flushing
dj
viewed
serious
discontin
grossbard
better
outpatient
143a
santarossa
2376
cua
ao
700
spend
sci
subsequent
spittle
htm
inform
l8
diversity
discrepancies
etc
diagnosed
drugs
possinger
latter
approximately
zwaal
191
relieve
sd
bugat
primarily
corris
table
green
arterially
bassi
moscini
jaraiz
adak
vast
225
real
agent
david
could
128
rates
logical
gallstones
reynolds
research
considering
ja
surgically
425
procedures
donna
overcome
rt
offered
obrist
scenarios
prior
sperti
mmc
programs
located
aylesworth
manager
bsc
stability
calvert
outweighed
would
administered
puente
humphrey
european
significantly
ludwig
surviving
corgna
existence
get
global
adopted
stimulating
fuller
335
emphasise
pancreatic
submission
ovarian
paediatric
underwent
tomographic
563
approach
cumulative
efficacy
self
elsewhere
absence
incl
prevention
advisory
landi
mann
recommended
reduces
volume
malignan
kosmas
132
mental
van
valid
key
printed
collinson
likelihood
eickhoff
wessex
appear
dedemadi
derive
gas
0004
area
071
modelling
exist
preliminary
funding
stating
bond
card
smspalar
measures
grey
protracted
undergo
who
tools
previously
simple
editors
505
995
sea
increases
continuously
smoking
failure
factors
commonly
expected
calculation
1998
tester
staffordshire
portsmouth
l6900
reigate
causing
vokes
many
medicus
istics
numerical
author
jm
turning
vorin
planned
cholangio
inoperable
way
139
golightly
comments
identifier
178
remaining
representative
hallam
euro
brunel
losses
patient
illnesses
possibility
presented
her2
appraisal
surrogate
committees
riding
wong
variety
intake
account
compendium
alone
little
switch
s13
cancers82
ie
facs
espac1
questions
parameter
cctr
marangolo
relation
proxy
combina
inflated
uncertainty
beyond
bodies
dagenais
crc
score
storniolo
soc
dehydro
referenced
suggested
clearing
petite
alcohol
l300
bansback1
possible
multicenter
fluids
members
louvet
length
ala
turn
650
cost
pam
flinker
britain
excluding
hygiene
zalupski
eli
molecular
our
its
790
observations
cholangiopancreatography
islington
414
typically
scelzi
group
ch
lescure
payment
radio
biweekly
dialysis
paying
permit
dp
543
funded
submissions
great
classified
particular
than
deter
costing
effective
hepatic
chapter
giannakakis
surgeon
technology
effort
hainsworth
peripancreatic
richard
zero
2000
downley
data13
octreotide
jeremy
underlying
copy
rom
following
restrictions
malignancies
data
underestimated
l19
after
metastases
leech
rossi
epelbaum
difference
embase
allocated
rhg
rudolph
magnetic
compassionate
outlook
instrument
telling
overestimated
glaucoma
went
641
medications
new
evaluation
199713
870
entirely
ifn
vital
reviewed
states
cytopenia
respectively
needed
min
rau
prospective
communication
enhance
mailpoint
expensive
conclusion
carmichael
start
responders
rosenblatt
acknow
offers
mitomycin
earnshaw
haemoglobin
profile
generated
criticised
phillip
packing
pharaco
generally
gusmao
payable
kalligas
linnartz
tom
leucopenia
exceed
probability
escalation
nuffield
outs
adenocarcinoma
freely
l26
infusions
prognosis
trend
colleagues
payne
intent
ten
hutchinson
tration
external
blinded
material
vidal
groups
regarding
ceiling
kaplan
inahta
infirmary
detailed
most
look
900
199993
arterial
had
information
oncologists
delivered
completing
anticipated
ebdon
leicester
again
difluoro
discounted
much
861
doctor
romiti
199792
gibbs
assessing
lifetime
questioned
upon
enzyme
means
blind
fl
0002
likewise
underestimates
workers83
analyses
biomed
reasonable
producing
generalisability
barnett
strong
roversi
ci994
sustained
interferon
cisplatin
empirical
into
advanced
weekly
overlap
west
norwich
messori
devon
trial13
cologne
probably
stewart
john
igr
0022
seventeen
senior
increasing
nrr
alton
1993
hull
percentage
400
analysis
introduction
meaningless
fixed
oncolytics
riccardi
received
paper
prescribing
last
meucci
oncol
sarah
next
kwasny
oral
aylesbury
ranges
ambulatory
company
meth
progressive
helpline
industry
epidemiology
mg
ceresoli
younger
suboptimal
schedule
adults
applied
pr
jaundice
eccles
function
graham
techniques
biases
l2
non
against
regarded
fioretto
location
schaafsma
267a
society
label
needs
2990
cdsr
inside
ability
pharmacoeconomics
likely
tim
shorter
102
jenny
incre
survivals
sheridan
l1900
positive
pedrazzoli
feliu
necessarily
philip
qaly
recom
com
behalf
oriented
survival11
sweden
chemotherapies
diminish
marimastat
about_college
immunotherapy
qol
product
know
filters
consider
evalu
course
crellin
377
tempero
follows
females
american
despatch
involved
neoadjuvant
other
metastatic
significance
transient
investigator
confined
university
hitt
pharmacologic
another
resected
shortcomings
rr
125
s1
inhibitors
refractory
mrc
clinically
auc
relies
teams
275a
katherine
hawkins
ann
peripheral
nih
823
il
christie
lopez
morbidity
commissioning
washington
partial
reports
insufficient
localized
adjustments
inadequate
sex
well
office
potential
australia
proteinura
contraindicated
folinic
none
weiden
cancerstats
doxorubicin
pool
towards
beam
kr
divided
2403
subjective
cddp
glasziou
world
cordio
databases
trade
196
additionally
118
gl
jacobs
ramlau
offen
194
supplement
portenoy
muir
1989
1bq
ek
gelber
docetaxel
examined
various
derived
pubmed
copyright
july
possibly
physiotherapy
functional
haemolytic
terms
reichle
mosconi
warwick
shah
298a
andrew
460
marginal
hard
manage
attempted
solo
fying
managed
catheter
professionals
now
examines
100
lecturer
proved
visa
188011
titov
trochanowski
their
scale
relating
best
stevens
dunning
hoffman
tonato
included
interpretation
l640
far
required
2012
mccall
582
distribution
cancer
but
too
over
largely
tox
cct
1980
stapleton
matrix
coeliac
citation
urografin
androulakis
parameters
receive
evaluations
pastorelli
fund
especially
unlikely
group95
evidence
yardeni
variably
hstat
gemcita
1970s
920
rise
pancreat
projects
allows
howlett
rectal
500
based
delaloya
pivotal
extrapolation
assigned
arguments
residual
libraries
2459
peters
made
1039
field
ised
estimation
greater
such
heterogeneity
tam
degree
current
truro
doggett
investigational
gomez
intolerable
member
jon
hcl
computer
evaluate
ment
publications
sponsored
dummy
nr3
routinely
585
l24
constenla
295a
internet
separately
scientific
transcrip
cholangiocarcinoma
nine
closed
encing
giuliani
showed
international
tsavaris
psychology
reason
thereafter
achieve
pages
splenic
elevation
cancerweb
judith
contributes
kulke
lactate
days
gradual
750
healthcare
brazier
alter
updated
contributed
enderby
consequence
words
trends
use
despite
covariance
384
isation
johnson
estimator
1595
queen
weighted
trastuzumab
views
cancers
conference
aim
michael
brogan
bill
bilirubin
acta
rises
buckel
nucleoside
subsequently
establish
pointed
stages
languages
coordinator
britbio
conclusively
unfunded
mean
began
tumours
responsibility
rigge
efficiency
interleukin
returned
rotherberg
pean
2600
tolerated
declined
search
reilly
perspective
166
inhibits
gain
gives
tered
abstract
major
1323
identified92
issues
acknowledgements
above
1377
combined
reversible
symptomatic
monotherapy
aapro
modest
digestive
recruitment
chemotherapeutic
tumour
rct
previous
slack
regional
reduce
imagine
studied
argon
153
bulutlar
101
brodie
activity
res
tissues
sterling
resonance
goal
type
check
tarantini
groeningen
monash
explored
alastair
bachmann
south
vascular
front
measuring
medline
info
meeting
alison
alistair
website
116
confirmed
few
price
276a
domised
calculated
intervals
statistics4
products
hepatogastroenterology
poor
pharmaceuticals
990
resulting
tendi
treatments
3364
downloading
gasparini
understate
jovic
severs
reproductive
known
espinosa
differences
probl
maintenance
correspondence
aimed
ahrq
nothing
hochster
660
tiner
inpatient
line
searches
collette
330
kl
reflecting
stella
stated
house
concurrently
suffi
gov
plus
steward
investigations
centres
need
682
does
outside
validated
155
young
spiral
trials
analyses11
mergenthaler
working
difficult
statistics
uraemic
print
program
jakobs
hazardous
telephone
period
although
presents
accrued
284a
tolerable
stein
js
support
simister
physician
sue
car
extrapolated
malignancy
vided
mj
content
gains
hours
1694
negative
solely
fee
099
budget
rosenberg
geographical
s157
during
greatly
pounds
eisenber
vj
radiology
systemic
reyes
wright
oettle
rising
radstone
appendix
modes
l2300
cif
relative
cautions
open
duct
extended
rothenberg
eamonn
forms
argument
raderer
oxilaplatin
analgesic
inclusion
dixon
nasrallah
demonstrating
oesophageal
locoregionally
extraction
muler
induced
alexander
they
definition
1715
funes
fairly
fn
diagnosis
popula
tumor
meaningful
validation
ebrahim
swedish
mauer
staddon
according
experiencing
monthly
pelzer
gillian
cycle
options
joint
je
emotional
radiation
epirubicin
withdrawals
questionnaire
103883
271
mail
stenting
receiving
ns
date
median
unacceptable
aggregating
subject
biliary
system
month
pancreatitis
uncertain
neutropenia
enrolled
static
appears
exp
addition
accrue
purchasing
risk
balbiani
ulrich
ordinating
emcitabine
spiessi
retrieved
vadiaka
criticise
italian
similarly
goodman
doctype
benefit
bile
cis
taxotere
chemotherapy
clark
outcomes
l21
visit
case
observation
surface
pharmaceutical
c30
jane
lygs
sites
120
taylor
transtumoral
calcium
prove
inappropriate
emd
milton
continuous
dtb
cetuximab
1261
flec
east
9331il
improved
statements
ambord
english
corsi
varied
charity
kakolyris
sadikov
variability
dividing
121974
includes
active
accounting
impact
achieved
random
guideline
please
rajan
strated
clearinghouse
currently
mcgovern
partitioning
measurements
signs
appraisals
remains
home
cycles
provided
removed
relatively
ation
negrier
counties
nuclear
er
narimanov
demon
chemical
catalano
960
accuracy
aberdeen
types
naive
determine
nate
suppl
monitored
took
diet
ruairidh
presentation
fit
entering
letter
jackson
figer
304a
several
rest
keynes
seutter
fenwick
caution
comparable
approximate
might
injection
excerpta
colleagues12
prolonged
stable
treat
whose
corresponding
discussion
cole
alt
divides
555
started
ultrasound
second
alleviation
counts
work
casemix
boldrewood
593
hants
1940
s17
conducted
service
exceedingly
pro
three
reference
april
borner
two
arbitrary
each
subscribe
wish
workers13
technique
106
nitrocamptothecin
canterbury
tamoxifen
economics
belon
participants
weight
suggests
full
altman
whereby
searched
bucks
lenauer
limit
doubt
approved
fiebiger
spective
italy
consequently
l16
ations
valuable
one
kouroussis
estimated
module
547
robert
nightingale
outlined
ruiz
usa
weissman
csf
146
882
proportion
sequential
addressing
reasons
light
abbreviations
citabine
rule
cover
ga
l1261
medicines
mastercard
average
network
accounted
vaughn
carcinoma
sample
very
infection
status
313a
problem
immaterial
dilated
ordering
bine
melanie
prognostic
havant
291a
dosing
carol
gemcitabine
ancillary
2np
locally
demonstrates
ratio
appetite
dominated
rd
734
appropriateness
highlighted
conclude
friess
curatively
pd
nodes
decreases
data102
franklyn
quantity
facilities
vivian
wilke
intraarterial
keywords
ci
horizon
due
argued
collected
151
sponsors
etoposide
gi
often
cambridge
unresectable
wales
decline
staging
evaluated
changes
emea
areas
described
alberta
free
assuming
allow
hour
others
securely
pression
renal
sector
bj
optimum
orders
l7800
panopoulos
steve
proteinuria
robbins
ajm
royal
expressed
superiority
yet
aged
folfugem
massuti
official
ad
offset
305a
between
convenient
colleagues91
atlanta
controls
fail
347
ross
enable
lymph
flombaum
dose
trial
gebbia
neill
cassano
td
damages
winston
women
therapeutics
controlled
am
public
fully
taking
day
itative
agents
reflected
england
reproduced
checking
scientist
illness
able
companies
using
trapezoidal
vienna
since
advantage
reactions
platelet
1996
diabetes
nhs
dna
avicine
ever
122
cookson
normally
3198
locoregional
appeared
upper
assumptions
compare
literature
mc
9566
difluorocytidine
valencak
nj
3023
scanning
unable
exerted
ms
andre
definitive
mh
imaging
concluded
proc
mike
obtain
radcliffe
nci
studies95
spectively
sjoden
2004
wilking
calvert1
synthesis
sculpher
gemos
083
pancreatography
colleagues29
travel
level
concomitant
bull
ayres
haematological
spleen
uk
lowed
adminis
stents
guidelines
confirm
acsdept
slightly
cient
390
zd9331
study13
longer
scores
metastasized
calculations
indicates
originally
them
optimal
delays
bf
bristol
functioning
exists
dismissed
technol
flu
ascertained
liability
1772
analogue
explore
kent
midlands
nurses
exclusion
myelosup
duncan
cripps
fruit
confirms
evaluable
further
change
mullen
ccopgi
november
ca19
summary
superselective
compares
lenoir
nicolisi
step
titles
l18
infinity
286
considerations
florence
suitability
unknown
hand
leucovorin
gained
oncology
regionally
000
reviewer
gloucestershire
diagnostic
adjust
therapeutic
bulletin
excellence
association
hypofractionated
enables
instead
1500
discounting
l8650
canadian
former
expiry
secondly
controller
rm
ovid
across
marianne
reviewing
319a
paul
clear
sociology
take
261a
lindesay
ques
sutton
purchasers
zimmern
screening
impossible
linear
sellstrom
514
transfer
alonso
school
1994
otero
scaglietti
hospitals
officer
utilised
once
alterations
graph
strategy
kinder
scoping
288a
balosso
irinotecan
hospitalisation
unfortu
present
minimal
intervention
iv
analysed
assertions
2740
copies
interim
creatinine
version
114
common
health
innovative
precautions
241
tried
generalise
088
comparing
sang
104
general
maximum
katrina
ee
five
monographs
regimens
stomatitis
duodenum
538
521
prepared
012
list
out
neoplasia
modified
201
inst
falls
stage
core
extremely
po9
categories
jeannette
pump
strategies
social
raise
vanica
acid
short
utilising
luton
requires
looking
gp
32a
anecdotal
dezateux
hsru
altnagelvin
shaun
commenced
concealment
deoxycytidine
prices
nursing
involvement
investigation
trial29
require
requirement
synthesised
publisher
head
1366
dyspnoea
noted
madhok
interventions
unsuitable
3478
around
syndrome
not
peveler
mark
years
brown
url
tentative
loss
incremental
prioritisation
foundation
277
improvements
editorial
effectiveness
downstaging
remain
division
drop
informed
cascinu
cuckle
services
implies
remained
bedfordshire
almira
standard
workers
courses
community
myelosuppression
consumption
before
403
qual
vege
natl
implicated
statistically
high
availability
demonstrated
first
eguidelines
structure